nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP3A4—type 2 diabetes mellitus	0.168	1	CbGaD
Loratadine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0291	0.0473	CbGbCtD
Loratadine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0233	0.0378	CbGbCtD
Loratadine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0221	0.036	CbGbCtD
Loratadine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0211	0.0342	CbGbCtD
Loratadine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0208	0.0338	CbGbCtD
Loratadine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0203	0.033	CbGbCtD
Loratadine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0197	0.032	CbGbCtD
Loratadine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0194	0.0316	CbGbCtD
Loratadine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0188	0.0305	CbGbCtD
Loratadine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0186	0.0302	CbGbCtD
Loratadine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0177	0.0287	CbGbCtD
Loratadine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0177	0.0287	CbGbCtD
Loratadine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0173	0.0281	CbGbCtD
Loratadine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0163	0.0265	CbGbCtD
Loratadine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0157	0.0256	CbGbCtD
Loratadine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0153	0.0249	CbGbCtD
Loratadine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0147	0.0239	CbGbCtD
Loratadine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0147	0.0239	CbGbCtD
Loratadine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0143	0.0232	CbGbCtD
Loratadine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0136	0.022	CbGbCtD
Loratadine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0134	0.0218	CbGbCtD
Loratadine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0133	0.0215	CbGbCtD
Loratadine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0131	0.0213	CbGbCtD
Loratadine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0124	0.0201	CbGbCtD
Loratadine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.012	0.0195	CbGbCtD
Loratadine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0118	0.0192	CbGbCtD
Loratadine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0111	0.0181	CbGbCtD
Loratadine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0108	0.0176	CbGbCtD
Loratadine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0107	0.0173	CbGbCtD
Loratadine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0102	0.0165	CbGbCtD
Loratadine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00986	0.016	CbGbCtD
Loratadine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00979	0.0159	CbGbCtD
Loratadine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00976	0.0159	CbGbCtD
Loratadine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00944	0.0153	CbGbCtD
Loratadine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00904	0.0147	CbGbCtD
Loratadine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00854	0.0139	CbGbCtD
Loratadine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00827	0.0134	CbGbCtD
Loratadine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00752	0.0122	CbGbCtD
Loratadine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0073	0.0119	CbGbCtD
Loratadine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00688	0.0112	CbGbCtD
Loratadine—ABCB1—Losartan—type 2 diabetes mellitus	0.00667	0.0108	CbGbCtD
Loratadine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00647	0.0105	CbGbCtD
Loratadine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0062	0.0101	CbGbCtD
Loratadine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0062	0.0101	CbGbCtD
Loratadine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00587	0.00954	CbGbCtD
Loratadine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00437	0.00711	CbGbCtD
Loratadine—CYP3A4—Losartan—type 2 diabetes mellitus	0.004	0.0065	CbGbCtD
Loratadine—Desloratadine—CYP1A2—type 2 diabetes mellitus	0.000722	0.643	CrCbGaD
Loratadine—Azatadine—CYP3A4—type 2 diabetes mellitus	0.000401	0.357	CrCbGaD
Loratadine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00018	0.00112	CcSEcCtD
Loratadine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000179	0.00111	CcSEcCtD
Loratadine—Headache—Glipizide—type 2 diabetes mellitus	0.000179	0.00111	CcSEcCtD
Loratadine—Palpitations—Metformin—type 2 diabetes mellitus	0.000179	0.00111	CcSEcCtD
Loratadine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000179	0.00111	CcSEcCtD
Loratadine—Shock—Valsartan—type 2 diabetes mellitus	0.000179	0.00111	CcSEcCtD
Loratadine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000178	0.00111	CcSEcCtD
Loratadine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000178	0.00111	CcSEcCtD
Loratadine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000177	0.0011	CcSEcCtD
Loratadine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000177	0.0011	CcSEcCtD
Loratadine—Tension—Losartan—type 2 diabetes mellitus	0.000176	0.0011	CcSEcCtD
Loratadine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000176	0.0011	CcSEcCtD
Loratadine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000176	0.0011	CcSEcCtD
Loratadine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000176	0.00109	CcSEcCtD
Loratadine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000176	0.00109	CcSEcCtD
Loratadine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000176	0.00109	CcSEcCtD
Loratadine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000176	0.00109	CcSEcCtD
Loratadine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000176	0.00109	CcSEcCtD
Loratadine—Hypertension—Metformin—type 2 diabetes mellitus	0.000175	0.00109	CcSEcCtD
Loratadine—Nervousness—Losartan—type 2 diabetes mellitus	0.000175	0.00109	CcSEcCtD
Loratadine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000175	0.00109	CcSEcCtD
Loratadine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000174	0.00108	CcSEcCtD
Loratadine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000174	0.00108	CcSEcCtD
Loratadine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000174	0.00108	CcSEcCtD
Loratadine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00107	CcSEcCtD
Loratadine—Myalgia—Metformin—type 2 diabetes mellitus	0.000172	0.00107	CcSEcCtD
Loratadine—Chest pain—Metformin—type 2 diabetes mellitus	0.000172	0.00107	CcSEcCtD
Loratadine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000172	0.00107	CcSEcCtD
Loratadine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000171	0.00107	CcSEcCtD
Loratadine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000171	0.00107	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000171	0.00106	CcSEcCtD
Loratadine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00017	0.00106	CcSEcCtD
Loratadine—Discomfort—Metformin—type 2 diabetes mellitus	0.00017	0.00106	CcSEcCtD
Loratadine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00017	0.00106	CcSEcCtD
Loratadine—Nausea—Glipizide—type 2 diabetes mellitus	0.00017	0.00106	CcSEcCtD
Loratadine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00017	0.00105	CcSEcCtD
Loratadine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00017	0.00105	CcSEcCtD
Loratadine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000169	0.00105	CcSEcCtD
Loratadine—Pain—Gliclazide—type 2 diabetes mellitus	0.000169	0.00105	CcSEcCtD
Loratadine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000169	0.00105	CcSEcCtD
Loratadine—Rash—Glimepiride—type 2 diabetes mellitus	0.000168	0.00105	CcSEcCtD
Loratadine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000168	0.00104	CcSEcCtD
Loratadine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000168	0.00104	CcSEcCtD
Loratadine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000168	0.00104	CcSEcCtD
Loratadine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000167	0.00104	CcSEcCtD
Loratadine—Headache—Glimepiride—type 2 diabetes mellitus	0.000167	0.00104	CcSEcCtD
Loratadine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000167	0.00104	CcSEcCtD
Loratadine—Cough—Irbesartan—type 2 diabetes mellitus	0.000167	0.00104	CcSEcCtD
Loratadine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000167	0.00104	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000165	0.00103	CcSEcCtD
Loratadine—Agitation—Losartan—type 2 diabetes mellitus	0.000165	0.00103	CcSEcCtD
Loratadine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000165	0.00103	CcSEcCtD
Loratadine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000165	0.00103	CcSEcCtD
Loratadine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000165	0.00102	CcSEcCtD
Loratadine—Angioedema—Losartan—type 2 diabetes mellitus	0.000164	0.00102	CcSEcCtD
Loratadine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000164	0.00102	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000163	0.00102	CcSEcCtD
Loratadine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000163	0.00101	CcSEcCtD
Loratadine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000163	0.00101	CcSEcCtD
Loratadine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000163	0.00101	CcSEcCtD
Loratadine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000163	0.00101	CcSEcCtD
Loratadine—Shock—Metformin—type 2 diabetes mellitus	0.000163	0.00101	CcSEcCtD
Loratadine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000162	0.00101	CcSEcCtD
Loratadine—Malaise—Losartan—type 2 diabetes mellitus	0.000162	0.00101	CcSEcCtD
Loratadine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000162	0.00101	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000162	0.001	CcSEcCtD
Loratadine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000161	0.001	CcSEcCtD
Loratadine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000161	0.001	CcSEcCtD
Loratadine—Syncope—Losartan—type 2 diabetes mellitus	0.000161	0.001	CcSEcCtD
Loratadine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000161	0.001	CcSEcCtD
Loratadine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000161	0.000999	CcSEcCtD
Loratadine—Skin disorder—Metformin—type 2 diabetes mellitus	0.00016	0.000998	CcSEcCtD
Loratadine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00016	0.000995	CcSEcCtD
Loratadine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00016	0.000993	CcSEcCtD
Loratadine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000159	0.000989	CcSEcCtD
Loratadine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000159	0.000989	CcSEcCtD
Loratadine—Palpitations—Losartan—type 2 diabetes mellitus	0.000159	0.000988	CcSEcCtD
Loratadine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000158	0.000985	CcSEcCtD
Loratadine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000158	0.000984	CcSEcCtD
Loratadine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000158	0.000982	CcSEcCtD
Loratadine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000158	0.000982	CcSEcCtD
Loratadine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000158	0.000981	CcSEcCtD
Loratadine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000158	0.000981	CcSEcCtD
Loratadine—Cough—Losartan—type 2 diabetes mellitus	0.000157	0.000975	CcSEcCtD
Loratadine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000157	0.000974	CcSEcCtD
Loratadine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000156	0.000973	CcSEcCtD
Loratadine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000156	0.000973	CcSEcCtD
Loratadine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000156	0.000971	CcSEcCtD
Loratadine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000156	0.000971	CcSEcCtD
Loratadine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000156	0.000969	CcSEcCtD
Loratadine—Constipation—Valsartan—type 2 diabetes mellitus	0.000155	0.000965	CcSEcCtD
Loratadine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000155	0.000962	CcSEcCtD
Loratadine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000155	0.000961	CcSEcCtD
Loratadine—Hypotension—Metformin—type 2 diabetes mellitus	0.000154	0.00096	CcSEcCtD
Loratadine—Shock—Irbesartan—type 2 diabetes mellitus	0.000153	0.000954	CcSEcCtD
Loratadine—Pain—Orlistat—type 2 diabetes mellitus	0.000153	0.000953	CcSEcCtD
Loratadine—Myalgia—Losartan—type 2 diabetes mellitus	0.000153	0.000952	CcSEcCtD
Loratadine—Chest pain—Losartan—type 2 diabetes mellitus	0.000153	0.000952	CcSEcCtD
Loratadine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000153	0.000951	CcSEcCtD
Loratadine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000153	0.000951	CcSEcCtD
Loratadine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000152	0.000946	CcSEcCtD
Loratadine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000152	0.000943	CcSEcCtD
Loratadine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000152	0.000942	CcSEcCtD
Loratadine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000151	0.000942	CcSEcCtD
Loratadine—Tension—Ramipril—type 2 diabetes mellitus	0.000151	0.000941	CcSEcCtD
Loratadine—Discomfort—Losartan—type 2 diabetes mellitus	0.000151	0.00094	CcSEcCtD
Loratadine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000151	0.000939	CcSEcCtD
Loratadine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000151	0.000937	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000151	0.000936	CcSEcCtD
Loratadine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00015	0.000936	CcSEcCtD
Loratadine—Nervousness—Ramipril—type 2 diabetes mellitus	0.00015	0.000931	CcSEcCtD
Loratadine—Dry mouth—Losartan—type 2 diabetes mellitus	0.00015	0.000931	CcSEcCtD
Loratadine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000148	0.000922	CcSEcCtD
Loratadine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000148	0.000922	CcSEcCtD
Loratadine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000148	0.000919	CcSEcCtD
Loratadine—Somnolence—Metformin—type 2 diabetes mellitus	0.000147	0.000913	CcSEcCtD
Loratadine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000147	0.000912	CcSEcCtD
Loratadine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000147	0.000911	CcSEcCtD
Loratadine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000146	0.000906	CcSEcCtD
Loratadine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000145	0.000904	CcSEcCtD
Loratadine—Shock—Losartan—type 2 diabetes mellitus	0.000144	0.000898	CcSEcCtD
Loratadine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000144	0.000895	CcSEcCtD
Loratadine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000143	0.000892	CcSEcCtD
Loratadine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000143	0.00089	CcSEcCtD
Loratadine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000143	0.000889	CcSEcCtD
Loratadine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000143	0.000888	CcSEcCtD
Loratadine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000143	0.000887	CcSEcCtD
Loratadine—Fatigue—Metformin—type 2 diabetes mellitus	0.000142	0.000886	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000142	0.000883	CcSEcCtD
Loratadine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000142	0.000881	CcSEcCtD
Loratadine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000142	0.000881	CcSEcCtD
Loratadine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000142	0.000881	CcSEcCtD
Loratadine—Agitation—Ramipril—type 2 diabetes mellitus	0.000142	0.000881	CcSEcCtD
Loratadine—Constipation—Metformin—type 2 diabetes mellitus	0.000141	0.000878	CcSEcCtD
Loratadine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000141	0.000876	CcSEcCtD
Loratadine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00014	0.00087	CcSEcCtD
Loratadine—Vomiting—Glyburide—type 2 diabetes mellitus	0.00014	0.000869	CcSEcCtD
Loratadine—Malaise—Ramipril—type 2 diabetes mellitus	0.000139	0.000864	CcSEcCtD
Loratadine—Rash—Glyburide—type 2 diabetes mellitus	0.000139	0.000862	CcSEcCtD
Loratadine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000139	0.000862	CcSEcCtD
Loratadine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000139	0.000861	CcSEcCtD
Loratadine—Syncope—Ramipril—type 2 diabetes mellitus	0.000138	0.00086	CcSEcCtD
Loratadine—Headache—Glyburide—type 2 diabetes mellitus	0.000138	0.000857	CcSEcCtD
Loratadine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000137	0.000853	CcSEcCtD
Loratadine—Hypotension—Losartan—type 2 diabetes mellitus	0.000137	0.000852	CcSEcCtD
Loratadine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000136	0.000847	CcSEcCtD
Loratadine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000136	0.000847	CcSEcCtD
Loratadine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000135	0.000842	CcSEcCtD
Loratadine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000135	0.00084	CcSEcCtD
Loratadine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000135	0.00084	CcSEcCtD
Loratadine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000135	0.000837	CcSEcCtD
Loratadine—Cough—Ramipril—type 2 diabetes mellitus	0.000135	0.000836	CcSEcCtD
Loratadine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000134	0.000836	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000134	0.000831	CcSEcCtD
Loratadine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000133	0.000829	CcSEcCtD
Loratadine—Pain—Irbesartan—type 2 diabetes mellitus	0.000133	0.000829	CcSEcCtD
Loratadine—Insomnia—Losartan—type 2 diabetes mellitus	0.000133	0.000825	CcSEcCtD
Loratadine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000132	0.000819	CcSEcCtD
Loratadine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000131	0.000816	CcSEcCtD
Loratadine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000131	0.000816	CcSEcCtD
Loratadine—Nausea—Glyburide—type 2 diabetes mellitus	0.000131	0.000812	CcSEcCtD
Loratadine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000131	0.000812	CcSEcCtD
Loratadine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000131	0.000812	CcSEcCtD
Loratadine—Somnolence—Losartan—type 2 diabetes mellitus	0.00013	0.000811	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00013	0.00081	CcSEcCtD
Loratadine—Asthenia—Valsartan—type 2 diabetes mellitus	0.00013	0.000809	CcSEcCtD
Loratadine—Discomfort—Ramipril—type 2 diabetes mellitus	0.00013	0.000806	CcSEcCtD
Loratadine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000129	0.000803	CcSEcCtD
Loratadine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000129	0.0008	CcSEcCtD
Loratadine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000128	0.000799	CcSEcCtD
Loratadine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000128	0.000798	CcSEcCtD
Loratadine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000127	0.000793	CcSEcCtD
Loratadine—Fatigue—Losartan—type 2 diabetes mellitus	0.000127	0.000787	CcSEcCtD
Loratadine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000126	0.000782	CcSEcCtD
Loratadine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000126	0.000781	CcSEcCtD
Loratadine—Constipation—Losartan—type 2 diabetes mellitus	0.000125	0.00078	CcSEcCtD
Loratadine—Pain—Losartan—type 2 diabetes mellitus	0.000125	0.00078	CcSEcCtD
Loratadine—Rash—Gliclazide—type 2 diabetes mellitus	0.000125	0.000774	CcSEcCtD
Loratadine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000124	0.000773	CcSEcCtD
Loratadine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000124	0.000772	CcSEcCtD
Loratadine—Shock—Ramipril—type 2 diabetes mellitus	0.000124	0.00077	CcSEcCtD
Loratadine—Headache—Gliclazide—type 2 diabetes mellitus	0.000124	0.000769	CcSEcCtD
Loratadine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000123	0.000767	CcSEcCtD
Loratadine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000123	0.000766	CcSEcCtD
Loratadine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000123	0.000766	CcSEcCtD
Loratadine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000123	0.000763	CcSEcCtD
Loratadine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000123	0.000763	CcSEcCtD
Loratadine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000122	0.00076	CcSEcCtD
Loratadine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000121	0.000752	CcSEcCtD
Loratadine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00012	0.000746	CcSEcCtD
Loratadine—Dizziness—Valsartan—type 2 diabetes mellitus	0.00012	0.000746	CcSEcCtD
Loratadine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000119	0.000737	CcSEcCtD
Loratadine—Asthenia—Metformin—type 2 diabetes mellitus	0.000119	0.000737	CcSEcCtD
Loratadine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000118	0.000731	CcSEcCtD
Loratadine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000117	0.000729	CcSEcCtD
Loratadine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000116	0.000721	CcSEcCtD
Loratadine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000116	0.000721	CcSEcCtD
Loratadine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000115	0.000717	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000115	0.000713	CcSEcCtD
Loratadine—Rash—Valsartan—type 2 diabetes mellitus	0.000114	0.000711	CcSEcCtD
Loratadine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000114	0.000711	CcSEcCtD
Loratadine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000114	0.000709	CcSEcCtD
Loratadine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000114	0.000708	CcSEcCtD
Loratadine—Headache—Valsartan—type 2 diabetes mellitus	0.000114	0.000707	CcSEcCtD
Loratadine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000113	0.000703	CcSEcCtD
Loratadine—Rash—Orlistat—type 2 diabetes mellitus	0.000113	0.000703	CcSEcCtD
Loratadine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000113	0.000702	CcSEcCtD
Loratadine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000113	0.000702	CcSEcCtD
Loratadine—Headache—Orlistat—type 2 diabetes mellitus	0.000112	0.000698	CcSEcCtD
Loratadine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000696	CcSEcCtD
Loratadine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000112	0.000695	CcSEcCtD
Loratadine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000111	0.000689	CcSEcCtD
Loratadine—Dizziness—Metformin—type 2 diabetes mellitus	0.000109	0.000679	CcSEcCtD
Loratadine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000675	CcSEcCtD
Loratadine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000108	0.000674	CcSEcCtD
Loratadine—Nausea—Valsartan—type 2 diabetes mellitus	0.000108	0.00067	CcSEcCtD
Loratadine—Constipation—Ramipril—type 2 diabetes mellitus	0.000108	0.000669	CcSEcCtD
Loratadine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000663	CcSEcCtD
Loratadine—Nausea—Orlistat—type 2 diabetes mellitus	0.000106	0.000662	CcSEcCtD
Loratadine—Asthenia—Losartan—type 2 diabetes mellitus	0.000105	0.000655	CcSEcCtD
Loratadine—Vomiting—Metformin—type 2 diabetes mellitus	0.000105	0.000653	CcSEcCtD
Loratadine—Rash—Metformin—type 2 diabetes mellitus	0.000104	0.000648	CcSEcCtD
Loratadine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000104	0.000647	CcSEcCtD
Loratadine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000104	0.000645	CcSEcCtD
Loratadine—Headache—Metformin—type 2 diabetes mellitus	0.000104	0.000644	CcSEcCtD
Loratadine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000103	0.000641	CcSEcCtD
Loratadine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000103	0.00064	CcSEcCtD
Loratadine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.0001	0.000624	CcSEcCtD
Loratadine—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000618	CcSEcCtD
Loratadine—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000618	CcSEcCtD
Loratadine—Vomiting—Irbesartan—type 2 diabetes mellitus	9.91e-05	0.000616	CcSEcCtD
Loratadine—Rash—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000611	CcSEcCtD
Loratadine—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.000611	CcSEcCtD
Loratadine—Nausea—Metformin—type 2 diabetes mellitus	9.81e-05	0.00061	CcSEcCtD
Loratadine—Headache—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.000607	CcSEcCtD
Loratadine—Dizziness—Losartan—type 2 diabetes mellitus	9.7e-05	0.000603	CcSEcCtD
Loratadine—Vomiting—Losartan—type 2 diabetes mellitus	9.33e-05	0.00058	CcSEcCtD
Loratadine—Nausea—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.000576	CcSEcCtD
Loratadine—Rash—Losartan—type 2 diabetes mellitus	9.25e-05	0.000575	CcSEcCtD
Loratadine—Dermatitis—Losartan—type 2 diabetes mellitus	9.24e-05	0.000575	CcSEcCtD
Loratadine—Headache—Losartan—type 2 diabetes mellitus	9.19e-05	0.000572	CcSEcCtD
Loratadine—Asthenia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000561	CcSEcCtD
Loratadine—Nausea—Losartan—type 2 diabetes mellitus	8.72e-05	0.000542	CcSEcCtD
Loratadine—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.61e-05	0.000535	CcSEcCtD
Loratadine—Dizziness—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000517	CcSEcCtD
Loratadine—Vomiting—Ramipril—type 2 diabetes mellitus	8e-05	0.000497	CcSEcCtD
Loratadine—Rash—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000493	CcSEcCtD
Loratadine—Dermatitis—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000493	CcSEcCtD
Loratadine—Headache—Ramipril—type 2 diabetes mellitus	7.88e-05	0.00049	CcSEcCtD
Loratadine—Nausea—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000465	CcSEcCtD
Loratadine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.28e-06	0.000114	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.26e-06	0.000114	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.26e-06	0.000114	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.26e-06	0.000114	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.25e-06	0.000114	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	6.23e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.23e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.21e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.21e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.21e-06	0.000113	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.18e-06	0.000112	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	6.16e-06	0.000112	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	6.16e-06	0.000112	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	6.15e-06	0.000112	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.09e-06	0.000111	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	6.09e-06	0.000111	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.08e-06	0.00011	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.04e-06	0.00011	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.01e-06	0.000109	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.01e-06	0.000109	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	6e-06	0.000109	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	6e-06	0.000109	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.97e-06	0.000109	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.96e-06	0.000108	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.96e-06	0.000108	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.95e-06	0.000108	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.91e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	5.9e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	5.9e-06	0.000107	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.87e-06	0.000107	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.86e-06	0.000106	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.76e-06	0.000105	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.76e-06	0.000105	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.75e-06	0.000104	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.75e-06	0.000104	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.75e-06	0.000104	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.75e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.73e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.7e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.7e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.68e-06	0.000103	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.67e-06	0.000103	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.66e-06	0.000103	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.66e-06	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.63e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.61e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.61e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.6e-06	0.000102	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.52e-06	0.0001	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.52e-06	0.0001	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.51e-06	0.0001	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.47e-06	9.94e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.45e-06	9.89e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	5.43e-06	9.87e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.43e-06	9.86e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.43e-06	9.86e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	5.4e-06	9.81e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.38e-06	9.78e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.38e-06	9.78e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	5.29e-06	9.6e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	5.19e-06	9.43e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.15e-06	9.35e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.14e-06	9.33e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.13e-06	9.32e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.12e-06	9.3e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.09e-06	9.24e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	5.09e-06	9.24e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	5.08e-06	9.23e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	5.06e-06	9.2e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	5.06e-06	9.2e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.04e-06	9.16e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.03e-06	9.13e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.03e-06	9.13e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5e-06	9.08e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.97e-06	9.02e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.97e-06	9.02e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.97e-06	9.02e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.94e-06	8.98e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.93e-06	8.96e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.88e-06	8.86e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.87e-06	8.84e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.85e-06	8.81e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.78e-06	8.68e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.74e-06	8.61e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.73e-06	8.6e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.72e-06	8.57e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.68e-06	8.51e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.68e-06	8.51e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.68e-06	8.5e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.68e-06	8.5e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.67e-06	8.49e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.66e-06	8.46e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.64e-06	8.43e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.64e-06	8.43e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.63e-06	8.41e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.62e-06	8.39e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.61e-06	8.37e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.6e-06	8.35e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.59e-06	8.34e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.58e-06	8.33e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.56e-06	8.29e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.56e-06	8.29e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.56e-06	8.29e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.56e-06	8.28e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.54e-06	8.24e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.53e-06	8.24e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.52e-06	8.21e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.52e-06	8.21e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.48e-06	8.14e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.46e-06	8.1e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.45e-06	8.09e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.44e-06	8.06e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.43e-06	8.04e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.42e-06	8.03e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.41e-06	8.01e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.4e-06	8e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.4e-06	7.99e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.36e-06	7.93e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	4.35e-06	7.9e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.35e-06	7.89e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.34e-06	7.88e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.3e-06	7.82e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.3e-06	7.81e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.3e-06	7.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	4.29e-06	7.8e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.26e-06	7.74e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.24e-06	7.7e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.22e-06	7.67e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.22e-06	7.67e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.17e-06	7.58e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.17e-06	7.58e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.16e-06	7.55e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.15e-06	7.54e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.15e-06	7.54e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.13e-06	7.51e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.13e-06	7.51e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.12e-06	7.48e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.09e-06	7.44e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.09e-06	7.44e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.09e-06	7.44e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.09e-06	7.43e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.07e-06	7.39e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.05e-06	7.35e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.02e-06	7.3e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.01e-06	7.29e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4e-06	7.26e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.99e-06	7.25e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.98e-06	7.23e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.96e-06	7.2e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.96e-06	7.2e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.94e-06	7.16e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.9e-06	7.08e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.9e-06	7.08e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.88e-06	7.05e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.87e-06	7.03e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.84e-06	6.97e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.84e-06	6.97e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.8e-06	6.91e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.8e-06	6.91e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.79e-06	6.88e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.79e-06	6.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.77e-06	6.84e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.77e-06	6.84e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.76e-06	6.84e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.75e-06	6.8e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.74e-06	6.8e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.73e-06	6.78e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.72e-06	6.75e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.7e-06	6.72e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.7e-06	6.72e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.64e-06	6.62e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.61e-06	6.56e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.58e-06	6.51e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.57e-06	6.49e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.55e-06	6.45e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.55e-06	6.45e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.55e-06	6.45e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.54e-06	6.44e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.54e-06	6.43e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.53e-06	6.41e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.5e-06	6.36e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.41e-06	6.19e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.38e-06	6.14e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.32e-06	6.02e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.3e-06	6e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.26e-06	5.92e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.26e-06	5.92e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.24e-06	5.88e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.23e-06	5.86e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.2e-06	5.81e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.18e-06	5.77e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.11e-06	5.65e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-06	5.6e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.06e-06	5.56e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.06e-06	5.56e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.05e-06	5.54e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.05e-06	5.53e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.04e-06	5.52e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.02e-06	5.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.02e-06	5.49e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3e-06	5.46e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.99e-06	5.43e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.98e-06	5.41e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.97e-06	5.39e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.93e-06	5.32e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.92e-06	5.3e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.91e-06	5.28e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.91e-06	5.28e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.84e-06	5.16e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.84e-06	5.16e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.84e-06	5.15e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.8e-06	5.08e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.79e-06	5.06e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.79e-06	5.06e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.77e-06	5.04e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.73e-06	4.95e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.72e-06	4.94e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.71e-06	4.93e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.68e-06	4.86e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.68e-06	4.86e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.66e-06	4.83e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-06	4.82e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-06	4.82e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.65e-06	4.81e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.61e-06	4.75e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.6e-06	4.72e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.51e-06	4.56e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.49e-06	4.52e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.46e-06	4.47e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.45e-06	4.44e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.44e-06	4.43e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.43e-06	4.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.38e-06	4.33e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.34e-06	4.26e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.33e-06	4.24e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.31e-06	4.19e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.03e-06	3.69e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.99e-06	3.62e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.88e-06	3.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.83e-06	3.32e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.75e-06	3.18e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.75e-06	3.18e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.73e-06	3.14e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	2.91e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.5e-06	2.72e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	2.43e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.3e-06	2.37e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	2.23e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	2.21e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.04e-07	1.46e-05	CbGpPWpGaD
